Allentown LLC acquires biological decontamination company ClorDiSys

Allentown, a provider of life science solutions, on Tuesday said it acquired ClorDiSys to further expand its footprint in the global biomedical research and life science markets.

ClorDiSys is a family-owned and -operated company that began in 2001 as a decontamination equipment provider but quickly added surface-top disinfection products, as well as on-site decontamination services, to its portfolio to better address customer challenges. Since then, ClorDiSys has provided decontamination solutions to customers worldwide and across many industries.

“In pursuing our strategy to provide a full spectrum of high-science equipment, consumables and services to our trusted biomedical research customers, and broadening our offerings and scientific services into adjacent life science industries, we’re thrilled when we find a leading organization that can help us pursue our goals.,” Charles Simmons, CEO of Allentown said. “ClorDiSys is that type of company, offering innovative and effective decontamination solutions with integrity and care, perfectly aligned with our cause to improve science and lifesaving research.”

Dane Kmetz, vice president of mergers & acquisitions and business development, added: “Acquiring best-in-class companies with high-performing teams and customer-centric solutions continues to be the focal point of our growth strategy. We welcome ClorDiSys to the Allentown family and look forward to expanding the reach of their mission-critical products and services.”

With the acquisition of ClorDiSys Allentown will add decontamination, disinfection and sterilization services to its solution offerings. Allentown said this new capability will help it close the loop on crucial vivarium services it already provides, allowing for the decontamination and recommissioning of essential research equipment back into service.

This acquisition is also in line with Allentown’s commitment to innovation and an expansion of scientific service offerings for the vivarium and broader life science markets.